Search

Displaying results 6151 - 6160 of 6189 in total
  1. Drug

    Amdoxovir

    go.drugbank.com/drugs/DB06619
    Investigational

  2. Drug

    Enrasentan

    go.drugbank.com/drugs/DB06460
    Experimental

    Categories: Endothelin Receptor Antagonists
  3. Drug

    RDEA806

    go.drugbank.com/drugs/DB05228
    Investigational

    RDEA806 is a new HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with a high genetic barrier to resistance and a broad spectrum of activity.

  4. Drug

    Tifuvirtide

    go.drugbank.com/drugs/DB05413
    Investigational

    Tifuvirtide is the first members of a new class of anti-HIV drugs which is also called fusion inhibitors. It has received fast-track designation from the FDA and is in Phase I/II clinical testing.

  5. Drug

    P54

    go.drugbank.com/drugs/DB05451
    Experimental

    P54 reduces the inflammation associated with cancer/tumors, Crohn's disease, inflammatory bowel disease, osteoarthritis, and ulcerative colitis. It inhibits the induction of the enzyme NFkB, thereby inhibiting downstream inflammatory gen...

  6. Drug

    Capravirine

    go.drugbank.com/drugs/DB08502
    Investigational

  7. Drug

    Ridaforolimus

    go.drugbank.com/drugs/DB06233
    Investigational

  8. Drug

    Bavituximab

    go.drugbank.com/drugs/DB05136
    Investigational

    Bavituximab is a chimeric Anti-PS monoclonal antibody analog which is used to potentially treat cancers and viral infections. It binds to phosphatidylserine and other exposed host cell lipids when induced by cellular stress. Additional a...

  9. Drug

    Volociximab

    go.drugbank.com/drugs/DB06647
    Investigational

  10. Drug

    Naproxcinod

    go.drugbank.com/drugs/DB06682
    Investigational